{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":324,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-09-14T18:21:24.973502+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Drug Launch Success In A Changing Commercial Landscape With ACMA's William Soliman, Ph.D.","slug":"drug-launch-success-in-a-changing-commercial-landscape-with-acma-s-william-soliman-ph-d","published_at":"2026-06-15T10:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/drug-launch-success-in-a-changing-commercial-landscape-with-acma-s-william-soliman-ph-d","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/19321763-drug-launch-success-in-a-changing-commercial-landscape-with-acma-s-william-soliman-ph-d.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/19321763-drug-launch-success-in-a-changing-commercial-landscape-with-acma-s-william-soliman-ph-d.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, William Soliman, Founder and CEO of the Accreditation Council for Medical Affairs (ACMA), and Founder and CIO of White Manna Capital Partners, talks about why biotech drug launches so often miss expectations, and how to build an integrated commercialization plan that holds up with physicians, patients, and payers. William also describes the evolution in medical affairs, why standards and...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, William Soliman, Founder and CEO of the Accredit…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3318,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/drug-launch-success-in-a-changing-commercial-landscape-with-acma-s-william-soliman-ph-d/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/drug-launch-success-in-a-changing-commercial-landscape-with-acma-s-william-soliman-ph-d.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}